FDA Approves Automatic Blood Glucose Monitoring System from Intuity Medical

Intuity Medical announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market the POGO Automatic Blood Glucose Monitoring System. The POGO System is the first blood glucose meter and multi-test cartridge to provide automatic testing with lancing, blood collection and analysis in one easy step. By combining all of the necessary blood glucose testing supplies into a convenient, selfcontained 10-test cartridge, POGO provides ease of use and discretion for millions of patients who need to regularly test their blood glucose in the management of their diabetes.

To perform a test, a patient simply presses the POGO test port, and POGO automatically lances the finger, collects

a blood sample and displays a result after a four-second countdown. The meter only requires a tiny blood sample of 0.25 microliters to analyze the glucose value. After all ten tests are complete, the patient disposes of the selfcontained cartridge, eliminating the need to handle used test strips or lancets since they remain inside the cartridge. This reduces the biohazards of used lancets and used test strips in public places.

“POGO brings new and unique features to home glucose monitoring,” commented Steve Edelman, MD, Clinical Professor of Medicine at the University of San Diego and Founding Director of Taking Control of Your Diabetes (TCOYD). “By reducing the number of steps and supplies needed to test, POGO addresses some of the common barriers to testing and gives patients a new way to test their glucose. As clinicians, making testing more convenient for the patient is essential to their diabetes care.”

When combined with Intuity Medical’s proprietary Patterns Diabetes Management application, a secure cloudbased system for managing glucose information, POGO provides both healthcare professionals and patients a comprehensive shared platform to detect and manage important patterns and trends that impact overall glucose control.

“POGO’s unique and patented technology has the potential to change the lives of millions of patients who see glucose testing as burdensome. More than half of the 287 patients in our pivotal clinical study reported that they would better adhere to their healthcare professional’s recommended testing schedule using POGO as compared to their current meter,” commented Emory V. Anderson, President and Chief Executive Officer, Intuity Medical. “With this FDA clearance milestone, the Intuity team will be focused on raising capital and building the company’s infrastructure for POGO’s commercial launch.”

Product information in details can be found from Intuity website.